Skip to main content

Table 3 Multivariable regression analysis result for prediction of mortality of patients with severe COVID-19

From: The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

  Adjusted OR (95% CI) P-value
IVIg (Treatment Group) 0.003 (0.001, 0.815) 0.042
Age 1.485 (1.011, 2.181) 0.044
Systolic BP 1.078 (0.924, 1.258) 0.336
Diastolic BP 0.543 (0.303, 0.972) 0.040
O2 saturation 0.841 (0.621, 1.138) 0.262
PLT 1.000 (0.999, 1.000) 0.132
LDH 1.023 (1.000,1.046) 0.048
BUN 1.136 (0.990,1.304) 0.069
Creatinine 0.018 (0.001,6.085) 0.177
PaO2 0.834 (0.593,1.173) 0.298
  1. IVIg Intravenous immunoglobulin, BP Blood pressure, LDH Lactate dehydrogenase, BUN Blood urea nitrogen, PaO2 Partial pressure of oxygen